Using the electronic baby bottle to support tongue-tie diagnosis in infants: a prospective study

Lene Dahl Siggard1, Dorte Rytter2, Torben Lildholdt3

  • 1Department of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Aalborg University Hospital, Aalborg, Denmark.

Insights

The electronic baby bottle (EBB) shows promise for assessing infant feeding issues like tongue-tie. While subjective utility was high, objective signal analysis is needed for accurate diagnosis and clinical use.

Area of Science:

  • Pediatric Otolaryngology
  • Infant Feeding Dynamics
  • Biomedical Engineering

Background:

  • Diagnosing tongue-tie (ankyloglossia) in infants is challenging due to a lack of objective diagnostic criteria.
  • Tongue-tie can significantly interfere with successful infant breastfeeding and bottle-feeding.
  • Novel technologies are needed to objectively assess infant suckling mechanics.

Purpose of the Study:

  • To evaluate the clinical utility and diagnostic value of the electronic baby bottle (EBB) in infants.
  • To assess the EBB's ability to record intraoral forces during suckling.
  • To compare EBB findings with clinical assessments and outcomes after frenotomy.

Main Methods:

  • A prospective cohort study involving 106 infants under 3 months across four ENT clinics.
  • Infants were assessed using the EBB and the Tonguewise Assessment of Buccal-Tongue tie in Infants (TABBY) scoring system.
  • Eighty-five infants underwent frenotomy, with 21 serving as controls.

Main Results:

  • The EBB demonstrated high diagnostic value scores, with no significant change observed post-frenotomy.
  • TABBY scores significantly improved after frenotomy, confirming anatomical changes.
  • Frenotomy led to significant improvements in caregiver-reported feeding symptoms.

Conclusions:

  • The EBB is rated subjectively useful by clinicians but requires automated signal analysis for objective diagnostic potential.
  • Current subjective interpretation of EBB data is insufficient for standalone diagnosis.
  • Further validation is necessary before recommending the EBB for routine clinical adoption.
Abstract